Journal article
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.
- Abstract:
-
The safety, immunogenicity, and efficacy of DNA and modified vaccinia virus Ankara (MVA) prime-boost regimes were assessed by using either thrombospondin-related adhesion protein (TRAP) with a multiple-epitope string ME (ME-TRAP) or the circumsporozoite protein (CS) of Plasmodium falciparum. Sixteen healthy subjects who never had malaria (malaria-naive subjects) received two priming vaccinations with DNA, followed by one boosting immunization with MVA, with either ME-TRAP or CS as the antigen...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Infection and immunity
- Volume:
- 74
- Issue:
- 10
- Pages:
- 5933-5942
- Publication date:
- 2006-10-01
- DOI:
- EISSN:
-
1098-5522
- ISSN:
-
0019-9567
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:1418
- UUID:
-
uuid:3d5e2d0d-e1ea-4023-92de-375f8deefc95
- Local pid:
- pubs:1418
- Source identifiers:
-
1418
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2006
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record